Edward Yau: The SAR government will establish the "Hong Kong Drug and Medical Device Regulatory Center" by 2026.

The Chief Executive of the Hong Kong Special Administrative Region, Carrie Lam, delivered a new policy address in the Legislative Council of the Hong Kong Special Administrative Region today. Lam stated that the SAR government will establish the "Hong Kong Drug and Medical Device Regulatory Centre" by 2026, and submit legislative proposals to regulate medical devices, aiming to become an internationally recognized authority in pharmaceutical and medical device regulation as soon as possible. The SAR government will expedite the "1+" new drug approval mechanism, pilot a priority approval for innovative drugs recommended by the Hospital Authority to treat severe or rare diseases, helping pharmaceutical companies bring innovative drugs to the market more quickly. The SAR government will also promote the standardization of clinical data in the Greater Bay Area, build a real-world data platform, and help pharmaceutical companies bring innovative drugs to the Mainland and international markets more quickly.